Preoperative Radiotherapy versus postoperative Radiotherapy after neoadjuvant Chemotherapy ("NeoRad") in High-risk Breast Cancer: a prospective, randomized, international multicenter Phase III Study

被引:0
作者
Matuschek, Christiane [1 ]
Jazmati, Danny [2 ]
Krug, David [3 ]
Corradini, Stefanie [4 ]
Fehm, Tanja [5 ]
Ruckhaeberle, Eugen [5 ]
Kuehn, Thorsten [6 ]
Stickeler, Elmar [7 ]
Nestle-Kraemling, Carolin [8 ]
Holtschmidt, Johannes [9 ]
Nekljudova, Valentina [9 ]
Loibl, Sibylle [9 ]
Budach, Wilfried [2 ]
机构
[1] Univ Bielefeld, Med Fak,Univ klin OWL, Univ klin Strahlentherapie & Radioonkol, Campus Klin Bielefeld, Teutoburger Str 50, D-33604 Bielefeld, Germany
[2] Heinrich Heine Univ Dusseldorf, Med Fak, Klin Strahlentherapie & Radiol Onkol, Dusseldorf, Germany
[3] Univ klin Hamburg Eppendorf, Klin Strahlentherapie, Klin Strahlentherapie & Radioonkol, MVZ, Hamburg, Germany
[4] LMU Munchen, Klin Radioonkol, Munich, Germany
[5] Univ klin Dusseldorf, Med Fak, Frauenklin, CIO ABCD, Dusseldorf, Germany
[6] Filderklin Stuttgart, Stuttgart, Germany
[7] Uniklin Aachen, Frauenklin, CIO ABCD, Aachen, Germany
[8] EVK Dusseldorf, Dusseldorf, Germany
[9] German Breast Grp, Neu Isenburg, Germany
来源
ONKOLOGIE | 2024年 / 30卷 / 09期
关键词
Brustkrebs; Bestrahlung; Neoadjuvanz; Krankheitsfreies uberleben; Nebenwirkungen; RADIATION-THERAPY;
D O I
10.1007/s00761-024-01568-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:840 / 844
页数:5
相关论文
共 50 条
  • [41] Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial
    Offersen, Birgitte V.
    Alsner, Jan
    Nielsen, Hanne M.
    Jakobsen, Erik H.
    Nielsen, Mette H.
    Krause, Mechthild
    Stenbygaard, Lars
    Mjaaland, Ingvil
    Schreiber, Andreas
    Kasti, Unn-Miriam
    Overgaard, Jens
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (31) : 3615 - +
  • [42] Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
    Nanos, Christos
    Souftas, Vasilios
    Zissimopoulos, Athanasios
    Koukourakis, Michael, I
    RADIATION ONCOLOGY JOURNAL, 2022, 40 (02): : 151 - 161
  • [43] Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer
    Geara, Fady B.
    Eid, Toufic
    Zouain, Nicolas
    Thebian, Ranim
    Andraos, Therese
    Chehab, Chirine
    Ramia, Paul
    Youssef, Bassem
    Zeidan, Youssef H.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (12): : 1257 - 1262
  • [44] Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
    Bolla, Michel
    van Poppel, Hein
    Tombal, Bertrand
    Vekemans, Kris
    Da Pozzo, Luigi
    de Reijke, Theo M.
    Verbaeys, Antony
    Bosset, Jean-Francois
    van Velthoven, Roland
    Colombel, Marc
    van de Beek, Cees
    Verhagen, Paul
    van den Bergh, Alphonsus
    Sternberg, Cora
    Gasser, Thomas
    van Tienhoven, Geertjan
    Scalliet, Pierre
    Haustermans, Karin
    Collette, Laurence
    LANCET, 2012, 380 (9858) : 2018 - 2027
  • [45] Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case
    Song, Yu-Chun
    Hu, Zhi-Hui
    Yan, Xue-Na
    Fang, Hui
    Tang, Yu
    Jing, Hao
    Men, Kuo
    Zhang, Na
    Zhang, Jun
    Jin, Jing
    Zhong, Qiu-Zi
    Ma, Jun
    Yang, Wei-Fang
    Zhong, Ya-Hua
    Dong, Li-Hua
    Wang, Xiao-Hong
    Wu, Hong-Fen
    Du, Xiang-Hui
    Hou, Xiao-Rong
    Tie, Jian
    Lu, Yu-Fei
    Zhao, Li-Na
    Li, Ye-Xiong
    Wang, Shu-Lian
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [46] Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case
    Yu-Chun Song
    Zhi-Hui Hu
    Xue-Na Yan
    Hui Fang
    Yu Tang
    Hao Jing
    Kuo Men
    Na Zhang
    Jun Zhang
    Jing Jin
    Qiu-Zi Zhong
    Jun Ma
    Wei-Fang Yang
    Ya-Hua Zhong
    Li-Hua Dong
    Xiao-Hong Wang
    Hong-Fen Wu
    Xiang-Hui Du
    Xiao-Rong Hou
    Jian Tie
    Yu-Fei Lu
    Li-Na Zhao
    Ye-Xiong Li
    Shu-Lian Wang
    Radiation Oncology, 18
  • [47] Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial
    Fonteyne, Valerie
    Dirix, P.
    Van Praet, C.
    Berghen, C.
    Albersen, M.
    Junius, S.
    Liefhooghe, N.
    Noe, L.
    De Meerleer, G.
    Ost, P.
    Villeirs, G.
    Verbeke, S.
    De Maeseneer, D.
    Rammant, E.
    Verghote, F.
    Elhaseen, E.
    De Man, K.
    Decaestecker, K.
    EUROPEAN UROLOGY FOCUS, 2022, 8 (05): : 1238 - 1245
  • [48] Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony
    Baron, Marie-Helene
    Jurgenliemk-Schulz, Ina M.
    Kitchener, Henry C.
    Nijman, Hans W.
    Wilson, Godfrey
    Brooks, Susan
    Carinelli, Silvestro
    Provencher, Diane
    Hanzen, Chantal
    Lutgens, Ludy C. H. W.
    Smit, Vincent T. H. B. M.
    Singh, Naveena
    Do, Viet
    D'Amico, Romerai
    Nout, Remi A.
    Feeney, Amanda
    Verhoeven-Adema, Karen W.
    Putter, Hein
    Creutzberg, Carien L.
    LANCET ONCOLOGY, 2018, 19 (03) : 295 - 309
  • [49] Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial
    Zheng, Rong
    Wang, Bi-Si
    Li, Zhihua
    Chi, Pan
    Xu, Benhua
    BMJ OPEN, 2023, 13 (03):
  • [50] Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer
    Thalgott, Mark
    Horn, Thomas
    Heck, Matthias M.
    Maurer, Tobias
    Eiber, Matthias
    Retz, Margitta
    Autenrieth, Michael
    Herkommer, Kathleen
    Krause, Bernd J.
    Gschwend, Juergen E.
    Treiber, Uwe
    Kuebler, Hubert R.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7